Top

Open Access 27-03-2024 | Alzheimer's Disease | Review

Arterial spin labelling magnetic resonance imaging and perfusion patterns in neurocognitive and other mental disorders: a systematic review

Authors: Rita Ferreira, António J. Bastos-Leite

Abstract

We reviewed 33 original research studies assessing brain perfusion, using consensus guidelines from a “white paper” issued by the International Society for Magnetic Resonance in Medicine Perfusion Study Group and the European Cooperation in Science and Technology Action BM1103 (“Arterial Spin Labelling Initiative in Dementia”; https://www.cost.eu/actions/BM1103/). The studies were published between 2011 and 2023 and included participants with subjective cognitive decline plus; neurocognitive disorders, including mild cognitive impairment (MCI), Alzheimer’s disease (AD), frontotemporal lobar degeneration (FTLD), dementia with Lewy bodies (DLB) and vascular cognitive impairment (VCI); as well as schizophrenia spectrum disorders, bipolar and major depressive disorders, autism spectrum disorder, attention-deficit/hyperactivity disorder, panic disorder and alcohol use disorder. Hypoperfusion associated with cognitive impairment was the major finding across the spectrum of cognitive decline. Regional hyperperfusion also was reported in MCI, AD, frontotemporal dementia phenocopy syndrome and VCI. Hypoperfused structures found to aid in diagnosing AD included the precunei and adjacent posterior cingulate cortices. Hypoperfused structures found to better diagnose patients with FTLD were the anterior cingulate cortices and frontal regions. Hypoperfusion in patients with DLB was found to relatively spare the temporal lobes, even after correction for partial volume effects. Hyperperfusion in the temporal cortices and hypoperfusion in the prefrontal and anterior cingulate cortices were found in patients with schizophrenia, most of whom were on medication and at the chronic stage of illness. Infratentorial structures were found to be abnormally perfused in patients with bipolar or major depressive disorders. Brain perfusion abnormalities were helpful in diagnosing most neurocognitive disorders. Abnormalities reported in VCI and the remaining mental disorders were heterogeneous and not generalisable.

Available only for authorised users

Alsop DC, Detre JA (1998) Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. Radiology 208(2):410–416. https://doi.org/10.1148/radiology.208.2.9680569CrossRefPubMed

Williams DS, Detre JA, Leigh JS et al (1992) Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci 89(1):212–216CrossRefPubMedPubMedCentral

Grade M, Hernandez Tamames JA, Pizzini FB et al (2015) A neuroradiologist’s guide to arterial spin labeling MRI in clinical practice. Neuroradiology 57(12):1181–1202. https://doi.org/10.1007/s00234-015-1571-z

Haller S, Zaharchuk G, Thomas DL et al (2016) Arterial spin labeling perfusion of the brain: emerging clinical applications. Radiology 281(2):337–356. https://doi.org/10.1148/radiol.2016150789CrossRefPubMed

Lindner T, Bolar DS, Achten E et al (2023) Current state and guidance on arterial spin labeling perfusion MRI in clinical neuroimaging. Magn Reson Med 89(5):2024–2047. https://doi.org/10.1002/mrm.29572CrossRefPubMedPubMedCentral

Taso M, Aramendia-Vidaurreta V, Englund EK et al (2023) Update on state-of-the-art for arterial spin labeling (ASL) human perfusion imaging outside of the brain. Magn Reson Med 89(5):1754–1776. https://doi.org/10.1002/mrm.29609CrossRefPubMed

Golay X, Guenther M (2012) Arterial spin labelling: final steps to make it a clinical reality. MAGMA 25(2):79–82. https://doi.org/10.1007/s10334-012-0308-9CrossRefPubMed

Alsop DC, Detre JA, Golay X et al (2015) Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 73(1):102–116. https://doi.org/10.1002/mrm.25197CrossRefPubMed

Alzheimer’s Association Report (2021) Alzheimer’s disease facts and figures. Alzheimers Dement 17(3):327–406. https://doi.org/10.1002/alz.12328CrossRef

10.

Sims JR, Zimmer JA, Evans CD et al (2023) Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA 330(6):512–527. https://doi.org/10.1001/jama.2023.13239CrossRefPubMedPubMedCentral

11.

Jonas K, Abi-Dargham A, Kotov R (2021) Two hypotheses on the high incidence of dementia in psychotic disorders. JAMA Psychiat 78(12):1305–1306. https://doi.org/10.1001/jamapsychiatry.2021.2584CrossRef

12.

Gossink FT, Dols A, Kerssens CJ et al (2016) Psychiatric diagnoses underlying the phenocopy syndrome of behavioural variant frontotemporal dementia. J Neurol Neurosurg Psychiatry 87(1):64–68. https://doi.org/10.1136/jnnp-2014-308284CrossRefPubMed

13.

Silveira C, Marques-Teixeira J, de Bastos-Leite AJ (2012) More than one century of schizophrenia: an evolving perspective. J Nerv Ment Dis 200(12):1054–1057. https://doi.org/10.1097/NMD.0b013e318275d249CrossRefPubMed

14.

American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Press, Washington DCCrossRef

15.

Insel T, Cuthbert B, Garvey M et al (2010) Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 167(7):748–751. https://doi.org/10.1176/appi.ajp.2010.09091379CrossRefPubMed

16.

Fallmar D, Haller S, Lilja J et al (2017) Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET. Eur Radiol 27(10):4237–4246. https://doi.org/10.1007/s00330-017-4784-1CrossRefPubMedPubMedCentral

17.

Jessen F, Amariglio RE, van Boxtel M et al (2014) A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimers Dement 10(6):844–852. https://doi.org/10.1016/j.jalz.2014.01.001CrossRefPubMed

18.

Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71CrossRefPubMedPubMedCentral

19.

National Heart, Lung and Blood Institute (2013) Study quality assessment tools, https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools (accessed 18 January 2024)

20.

Jarnum H, Eskildsen SF, Steffensen EG et al (2011) Longitudinal MRI study of cortical thickness, perfusion, and metabolite levels in major depressive disorder. Acta Psychiatr Scand 124(6):435–446. https://doi.org/10.1111/j.1600-0447.2011.01766.xCrossRefPubMed

21.

Binnewijzend MA, Kuijer JP, Benedictus MR et al (2013) Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology 267(1):221–230. https://doi.org/10.1148/radiol.12120928CrossRefPubMed

22.

Benedictus MR, Binnewijzend MA, Kuijer JP et al (2014) Brain volume and white matter hyperintensities as determinants of cerebral blood flow in Alzheimer’s disease. Neurobiol Aging 35(12):2665–2670. https://doi.org/10.1016/j.neurobiolaging.2014.06.001CrossRefPubMed

23.

Binnewijzend MA, Kuijer JP, van der Flier WM et al (2014) Distinct perfusion patterns in Alzheimer’s disease, frontotemporal dementia and dementia with Lewy bodies. Eur Radiol 24(9):2326–2333. https://doi.org/10.1007/s00330-014-3172-3CrossRefPubMed

24.

Ding B, Ling HW, Zhang Y et al (2014) Pattern of cerebral hyperperfusion in Alzheimer’s disease and amnestic mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging: initial experience. Clin Interv Aging 9:493–500. https://doi.org/10.2147/CIA.S58879CrossRefPubMedPubMedCentral

25.

Jann K, Hernandez LM, Beck-Pancer D et al (2015) Altered resting perfusion and functional connectivity of default mode network in youth with autism spectrum disorder. Brain Behav 5(9):e00358. https://doi.org/10.1002/brb3.358CrossRefPubMedPubMedCentral

26.

Liu Y, Zeng X, Wang Z et al (2015) Different post label delay cerebral blood flow measurements in patients with Alzheimer’s disease using 3D arterial spin labeling. Magn Reson Imaging 33(9):1019–1025. https://doi.org/10.1016/j.mri.2015.05.001CrossRefPubMed

27.

Zhu J, Zhuo C, Qin W et al (2015) Altered resting-state cerebral blood flow and its connectivity in schizophrenia. J Psychiatr Res 63:28–35. https://doi.org/10.1016/j.jpsychires.2015.03.002CrossRefPubMed

28.

Kaichi Y, Okada G, Takamura M et al (2016) Changes in the regional cerebral blood flow detected by arterial spin labeling after 6-week escitalopram treatment for major depressive disorder. J Affect Disord 194:135–143. https://doi.org/10.1016/j.jad.2015.12.062CrossRefPubMed

29.

Ma X, Wang D, Zhou Y et al (2016) Sex-dependent alterations in resting-state cerebral blood flow, amplitude of low-frequency fluctuations and their coupling relationship in schizophrenia. Aust N Z J Psychiatry 50(4):334–344. https://doi.org/10.1177/0004867415601728CrossRefPubMed

30.

Steketee RM, Bron EE, Meijboom R et al (2016) Early-stage differentiation between presenile Alzheimer’s disease and frontotemporal dementia using arterial spin labeling MRI. Eur Radiol 26(1):244–253. https://doi.org/10.1007/s00330-015-3789-xCrossRefPubMed

31.

Steketee RM, Meijboom R, Bron EE et al (2016) Structural and functional brain abnormalities place phenocopy frontotemporal dementia (FTD) in the FTD spectrum. NeuroImage Clin 11:595–605. https://doi.org/10.1016/j.nicl.2016.03.019CrossRefPubMedPubMedCentral

32.

Steketee RM, Meijboom R, de Groot M et al (2016) Concurrent white and gray matter degeneration of disease-specific networks in early-stage Alzheimer’s disease and behavioral variant frontotemporal dementia. Neurobiol Aging 43:119–128. https://doi.org/10.1016/j.neurobiolaging.2016.03.031CrossRefPubMed

33.

Zhao L, Wang Y, Jia Y et al (2016) Cerebellar microstructural abnormalities in bipolar depression and unipolar depression: a diffusion kurtosis and perfusion imaging study. J Affect Disord 195:21–31. https://doi.org/10.1016/j.jad.2016.01.042CrossRefPubMed

34.

Dolui S, Vidorreta M, Wang Z et al (2017) Comparison of PASL, PCASL, and background-suppressed 3D PCASL in mild cognitive impairment. Hum Brain Mapp 38(10):5260–5273. https://doi.org/10.1002/hbm.23732CrossRefPubMedPubMedCentral

35.

Leeuwis AE, Benedictus MR, Kuijer JPA et al (2017) Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer’s disease. Alzheimers Dement 13(5):531–540. https://doi.org/10.1016/j.jalz.2016.08.013CrossRefPubMed

36.

Zhu J, Zhuo C, Xu L et al (2017) Altered coupling between resting-state cerebral blood flow and functional connectivity in schizophrenia. Schizophr Bull 43(6):1363–1374. https://doi.org/10.1093/schbul/sbx051CrossRefPubMedPubMedCentral

37.

Anazodo UC, Finger E, Kwan BYM et al (2018) Using simultaneous PET/MRI to compare the accuracy of diagnosing frontotemporal dementia by arterial spin labelling MRI and FDG-PET. NeuroImage Clinical 17:405–414. https://doi.org/10.1016/j.nicl.2017.10.033CrossRefPubMed

38.

Huang CW, Hsu SW, Chang YT et al (2018) Cerebral perfusion insufficiency and relationships with cognitive deficits in Alzheimer’s disease: a multiparametric neuroimaging study. Sci Rep 8(1):1541. https://doi.org/10.1038/s41598-018-19387-xCrossRefPubMedPubMedCentral

39.

Kim J, Plitman E, Nakajima S et al (2019) Modulation of brain activity with transcranial direct current stimulation: targeting regions implicated in impaired illness awareness in schizophrenia. Eur Psychiatry 61:63–71. https://doi.org/10.1016/j.eurpsy.2019.06.007CrossRefPubMed

40.

Dai W, Chen M, Duan W et al (2020) Abnormal perfusion fluctuation and perfusion connectivity in bipolar disorder measured by dynamic arterial spin labeling. Bipolar Disord 22(4):401–410. https://doi.org/10.1111/bdi.12856CrossRefPubMed

41.

Ni MF, Wang XM, Wang HY et al (2020) Regional cortical thinning and cerebral hypoperfusion in patients with panic disorder. J Affect Disord 277:138–145. https://doi.org/10.1016/j.jad.2020.07.139CrossRefPubMed

42.

Tan YW, Liu L, Wang YF et al (2020) Alterations of cerebral perfusion and functional brain connectivity in medication-naive male adults with attention-deficit/hyperactivity disorder. CNS Neurosci Ther 26(2):197–206. https://doi.org/10.1111/cns.13185CrossRefPubMed

43.

Yang Z, Rong Y, Cao Z et al (2021) Microstructural and cerebral blood flow abnormalities in subjective cognitive decline plus: diffusional kurtosis imaging and three-dimensional arterial spin labeling study. Front Aging Neurosci 13:625843. https://doi.org/10.3389/fnagi.2021.625843CrossRefPubMedPubMedCentral

44.

Butcher TJ, Chumin EJ, West JD et al (2022) Cerebral blood flow in the salience network of individuals with alcohol use disorder. Alcohol Alcohol 57(4):445–451. https://doi.org/10.1093/alcalc/agab062CrossRefPubMed

45.

Chen F, Gong J, Chen G et al (2022) Shared and specific characteristics of regional cerebral blood flow and functional connectivity in unmedicated bipolar and major depressive disorders. J Affect Disord 309:77–84. https://doi.org/10.1016/j.jad.2022.04.099CrossRefPubMed

46.

Ssali T, Narciso L, Hicks J et al (2022) Concordance of regional hypoperfusion by pCASL MRI and (15)O-water PET in frontotemporal dementia: is pCASL an efficacious alternative? NeuroImage Clin 33:102950. https://doi.org/10.1016/j.nicl.2022.102950CrossRefPubMedPubMedCentral

47.

Gao Z, Zhou S, Zhu W et al (2023) Sex-dependent changes in emotional memory associated with cerebral blood flow alterations during Alzheimer’s disease progression. Neuroradiology 65(4):751–763. https://doi.org/10.1007/s00234-022-03099-1CrossRefPubMed

48.

Camargo A, Wang Z, Alzheimer’s Disease Neuroimaging Initiative (2023) Hypo- and hyper-perfusion in MCI and AD identified by different ASL MRI sequences. Brain Imaging Behav 17(3):306–319. https://doi.org/10.1007/s11682-023-00764-8CrossRefPubMedPubMedCentral

49.

Dong H, Guo L, Yang H et al (2023) Association between gray matter atrophy, cerebral hypoperfusion, and cognitive impairment in Alzheimer’s disease. Front Aging Neurosci 15:1129051. https://doi.org/10.3389/fnagi.2023.1129051CrossRefPubMedPubMedCentral

50.

Mao C, You H, Hou B et al (2023) Differentiation of Alzheimer’s disease from frontotemporal dementia and mild cognitive impairment based on arterial spin labeling magnetic resonance imaging: a pilot cross-sectional study from PUMCH dementia cohort. J Alzheimers Dis 93(2):509–519. https://doi.org/10.3233/JAD-221023CrossRefPubMed

51.

Ruan Z, Sun D, Zhou X et al (2023) Altered neurovascular coupling in patients with vascular cognitive impairment: a combined ASL-fMRI analysis. Front Aging Neurosci 15:1224525. https://doi.org/10.3389/fnagi.2023.1224525CrossRefPubMedPubMedCentral

52.

Zhu W, Gao Z, Li H et al (2023) Education reduces cognitive dysfunction in Alzheimer’s disease by changing regional cerebral perfusion: an in-vivo arterial spin labeling study. Neurol Sci 44(7):2349–2361. https://doi.org/10.1007/s10072-023-06696-xCrossRefPubMed

53.

Petersen RC, Doody R, Kurz A et al (2001) Current concepts in mild cognitive impairment. Arch Neurol 58(12):1985–1992. https://doi.org/10.1001/archneur.58.12.1985CrossRefPubMed

54.

Petersen RC, Stevens JC, Ganguli M et al (2001) Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Neurology 56(9):1133–1142. https://doi.org/10.1212/wnl.56.9.1133CrossRefPubMed

55.

Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256(3):183–194. https://doi.org/10.1111/j.1365-2796.2004.01388.xCrossRefPubMed

56.

Albert MS, DeKosky ST, Dickson D et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7(3):270–279. https://doi.org/10.1016/j.jalz.2011.03.008CrossRefPubMed

57.

McKhann G, Drachman D, Folstein M et al (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34(7):939–944. https://doi.org/10.1212/wnl.34.7.939CrossRefPubMed

58.

McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7(3):263–269. https://doi.org/10.1016/j.jalz.2011.03.005CrossRefPubMed

59.

Neary D, Snowden JS, Gustafson L et al (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51(6):1546–1554. https://doi.org/10.1212/wnl.51.6.1546CrossRefPubMed

60.

Gorno-Tempini ML, Hillis AE, Weintraub S et al (2011) Classification of primary progressive aphasia and its variants. Neurology 76(11):1006–1014. https://doi.org/10.1212/WNL.0b013e31821103e6CrossRefPubMedPubMedCentral

61.

Rascovsky K, Hodges JR, Knopman D et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134(Pt 9):2456–2477. https://doi.org/10.1093/brain/awr179CrossRefPubMedPubMedCentral

62.

McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65(12):1863–1872. https://doi.org/10.1212/01.wnl.0000187889.17253.b1CrossRefPubMed

63.

Skrobot OA, Black SE, Chen C et al (2018) Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study. Alzheimers Dement 14(3):280–292. https://doi.org/10.1016/j.jalz.2017.09.007CrossRefPubMed

64.

Leech R, Sharp DJ (2014) The role of the posterior cingulate cortex in cognition and disease. Brain 137(Pt 1):12–32. https://doi.org/10.1093/brain/awt162CrossRefPubMed

65.

Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198. https://doi.org/10.1016/0022-3956(75)90026-6

66.

Teng EL, Hasegawa K, Homma A et al (1994) The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 6(1):45–58. https://doi.org/10.1017/s1041610294001602

67.

Chelune GJ, Bornstein RA and Prifitera A (1990) The Wechsler memory scale—revised. In: Advances in Psychological Assessment Volume 7. Springer, Boston, pp 65–99. https://doi.org/10.1007/978-1-4613-0555-2_3

68.

Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261–276. https://doi.org/10.1093/schbul/13.2.261CrossRefPubMed

69.

Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62. https://doi.org/10.1136/jnnp.23.1.56CrossRefPubMedPubMedCentral

70.

Lord C, Risi S, Lambrecht L et al (2000) The Autism Diagnostic Observation Schedule-Generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30(3):205–223CrossRefPubMed

71.

Constantino JN, Davis SA, Todd RD et al (2003) Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised. J Autism Dev Disord 33(4):427–433. https://doi.org/10.1023/a:1025014929212CrossRefPubMed

72.

Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32(1):50–55. https://doi.org/10.1111/j.2044-8341.1959.tb00467.xCrossRefPubMed

73.

Shear MK, Brown TA, Barlow DH et al (1997) Multicenter collaborative panic disorder severity scale. Am J Psychiatry 154(11):1571–1575. https://doi.org/10.1176/ajp.154.11.1571CrossRefPubMed

74.

Saunders JB, Aasland OG, Babor TF et al (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption—II. Addiction 88(6):791–804. https://doi.org/10.1111/j.1360-0443.1993.tb02093.xCrossRefPubMed

75.

Bastos-Leite AJ, van der Flier WM, van Straaten EC et al (2007) The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia. Stroke 38(12):3182–3185. https://doi.org/10.1161/STROKEAHA.107.490102CrossRefPubMed

76.

Barkhof F, Fox NC, Bastos-Leite AJ et al (2011) Vascular dementia. In: Neuroimaging in dementia. 1st ed, Springer, Berlin, pp 137–176. https://doi.org/10.1007/978-3-642-00818-4_6

77.

Theberge J (2008) Perfusion magnetic resonance imaging in psychiatry. Top Magn Reson Imaging 19(2):111–130. https://doi.org/10.1097/RMR.0b013e3181808140CrossRefPubMed

78.

Marti-Bonmati L, Lull JJ, Garcia-Marti G et al (2007) Chronic auditory hallucinations in schizophrenic patients: MR analysis of the coincidence between functional and morphologic abnormalities. Radiology 244(2):549–556. https://doi.org/10.1148/radiol.2442060727CrossRefPubMed

79.

Bastos-Leite AJ, Ridgway GR, Silveira C et al (2015) Dysconnectivity within the default mode in first-episode schizophrenia: a stochastic dynamic causal modeling study with functional magnetic resonance imaging. Schizophr Bull 41(1):144–153. https://doi.org/10.1093/schbul/sbu080CrossRefPubMed

80.

Goldman-Rakic PS, Castner SA, Svensson TH et al (2004) Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology 174(1):3–16. https://doi.org/10.1007/s00213-004-1793-yCrossRefPubMed

81.

Weiduschat N, Dubin MJ (2013) Prefrontal cortical blood flow predicts response of depression to rTMS. J Affect Disord 150(2):699–702. https://doi.org/10.1016/j.jad.2013.04.049CrossRefPubMed

82.

Liu C, Wei H, Gong NJ et al (2015) Quantitative susceptibility mapping: contrast mechanisms and clinical applications. Tomography 1(1):3–17. https://doi.org/10.18383/j.tom.2015.00136CrossRefPubMedPubMedCentral

83.

Wierenga CE, Hays CC, Zlatar ZZ (2014) Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer’s disease. J Alzheimers Dis 42(Suppl 4):S411-419. https://doi.org/10.3233/JAD-141467CrossRefPubMedPubMedCentral

84.

Meeter LH, Kaat LD, Rohrer JD et al (2017) Imaging and fluid biomarkers in frontotemporal dementia. Nat Rev Neurol 13(7):406–419. https://doi.org/10.1038/nrneurol.2017.75CrossRefPubMed

85.

Clement P, Mutsaerts HJ, Vaclavu L et al (2018) Variability of physiological brain perfusion in healthy subjects: a systematic review of modifiers. J Cereb Blood Flow Metab 38(9):1418–1437. https://doi.org/10.1177/0271678X17702156CrossRefPubMed

Title: Arterial spin labelling magnetic resonance imaging and perfusion patterns in neurocognitive and other mental disorders: a systematic review
Authors: Rita Ferreira
António J. Bastos-Leite
Publication date: 27-03-2024
Publisher: Springer Berlin Heidelberg
Keywords: Alzheimer's Disease
Alzheimer's Disease
Mild Cognitive Impairment
Published in: Neuroradiology
Print ISSN: 0028-3940
Electronic ISSN: 1432-1920
DOI: https://doi.org/10.1007/s00234-024-03323-0

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Arterial spin labelling magnetic resonance imaging and perfusion patterns in neurocognitive and other mental disorders: a systematic review

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content